U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07053306) titled 'SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia' on June 26.
Brief Summary: To examine the 2-HIT hypothesis that the SGLT2i-induced stimulation of EGP, lipolysis, and ketone production requires the combination of volume depletion plus insulinopenia in T2D individuals.
Study Start Date: April 29
Study Type: INTERVENTIONAL
Condition:
Type 2 Diabetes
Intervention:
DRUG: Empagliflozin 25 MG
A medication used in the management and treatment of type 2 diabetes mellitus. It is in the sodium-glucose co-transporter (SGLT-2) class of medications.
Recruitment Status: RECRUITING
Sponsor: The University of Texas Health Scienc...